Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Rapidly Progressive Weakness in MGUS-Associated Chronic Inflammatory Demyelinating Polyneuropathy: A Rare Presentation and Review

Дата публикации: 20-07-2026 12:21:34

Monoclonal gammopathy of undetermined significance (MGUS) may be associated with peripheral neuropathy; however, IgG MGUS–associated chronic inflammatory demyelinating polyneuropathy (CIDP) is uncommon and generally follows a slowly progressive or relapsing course. We report a man in his early 40s who developed rapidly progressive sensorimotor weakness resulting in quadriparesis and inability to ambulate within eight weeks. Examination demonstrated severe proximal and distal weakness, glove-and-stocking sensory loss, and absent reflexes. Cerebrospinal fluid protein was markedly elevated, and nerve conduction studies/electromyography demonstrated acquired demyelination with secondary axonal loss. Evaluation identified IgG MGUS, supporting the diagnosis of MGUS-associated CIDP after alternative etiologies were excluded. Intravenous immunoglobulin was discontinued on day 3 following the development of a pulmonary embolism. The patient subsequently completed eight plasma-exchange sessions, with improvement in lower-extremity strength to 3/5, upper-extremity strength to 4/5, and sensory symptoms. He was discharged to rehabilitation with planned monthly plasma exchange.recognised clinical spectrum of IgG MGUS–associated CIDP and demonstrates that meaningful neurological improvement may occur with plasma exchange despite rapid progression and severe initial disability.

Основное содержимое страницы с новостью.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1First Effective Nanobody in Myasthenia Gravis Therapy010.527-07-2026
2Gefurulimab and Generalized Myasthenia Gravis010.4227-07-2026
3Chugai Files for Additional Indication of Enspryng as Japan’s Potential First Treatment for Prevention of Relapse in MOG Antibody-associated Disease012.631-07-2026
4Feasibility and outcomes of crossflow membrane plasmapheresis for long COVID in Suriname: a randomized double-blind placebo-controlled pilot trial [version 1; peer review: awaiting peer review]012.8805-08-2026
5Glycemic control predicts the Brain-derived neurotrophic factor levels in diabetic neuropathy patients with a diabetic duration of at least 5 years: A cross-sectional study [version 4; peer review: 2 approved]0709-06-2026
6EXCLUSIVE: 'MND is full of disappointments. I'm just lucky that I get mine every month, not every day' - Marcus Stewart on his battle with motor neurone disease08.2301-10-2023
7Sclerosi multipla, la svolta arriva da un farmaco già esistente: può riparare il sistema nervoso04.2822-01-2026
8These fat-filled brain cells may be making multiple sclerosis worse07.8829-06-2026
9Front Range Medical Center helps with Peripheral Neuropathy0208-07-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 7.82. Источник: www.cancertherjournal.com.